Antispasmodic agents for radial artery conduit.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23784

Enrollment

Registered

2013-04-19

Start date

2013-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment radial conduits in coronary artery bypass grafting

Interventions

This is a prospective randomized non-blinded study containing two groups of patients. In one group, the radial artery will be treated topically with the solution used in our daily practice which conta

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing isolated or combined CABG whereby the radial artery is used as a conduit with or without the use of other conduits.

Exclusion criteria

Exclusion criteria: Emergency Operation.

Design outcomes

Primary

Measure	Time frame
Comparison between verapamil and nicardipine in preventing spasm and increasing direct free flow through the radial artery conduit.	—

Secondary

Measure	Time frame
Effect of the two drugs on the incidence of perioperative ischemia and infarction.	—

Contacts

Public ContactI. Ozdemir

Michelangelolaan 2

ibrahim.ozdemir@cze.nl+31 (0)40 2398680

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)